Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells (2025)
- Authors:
- Silva, Jean Carlos Lipreri da
- Lima, Keli
- Ede, Benjamin
- Lazarini, Mariana
- Vicari, Hugo Passos
- Nogueira, Frederico Lisboa
- Clayton, Natasha S.
- Pinnell, Katy
- Silva, Wellington Fernandes da
- Bendit, Israel
- Ridley, Anne J.
- Rego, Eduardo Magalhães
- Velloso, Elvira Deolinda Rodrigues Pereira
- Costa-Lotufo, Leticia Veras
- Machado Neto, João Agostinho
- Silva, Jean Carlos Lipreri da
- USP affiliated authors: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM ; BENDIT, ISRAEL - FM ; REGO, EDUARDO MAGALHÃES - FM ; LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; LIMA, KELI CRISTINA DE - FM ; VICARI, HUGO PASSOS - ICB
- Unidades: FM; ICB
- DOI: 10.1016/j.ejphar.2024.177161
- Subjects: FARMACOLOGIA; LEUCEMIA; LINFOMA; NEOPLASIAS POR TIPO HISTOLÓGICO; CITOESQUELETO; FILAMENTOS CITOPLASMÁTICOS; ANTINEOPLÁSICOS; APOPTOSE; PROLIFERAÇÃO CELULAR; SOBREVIVÊNCIA CELULAR; ESTUDOS DE COORTES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 1879-0712
- Volume/Número/Paginação/Ano: v. 987, art. 177161, 13 p., 2025
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Jean Carlos Lipreri da et al. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, v. 987, p. 13 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.177161. Acesso em: 04 ago. 2025. -
APA
Silva, J. C. L. da, Lima, K., Ede, B., Lazarini, M., Vicari, H. P., Nogueira, F. L., et al. (2025). Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. European Journal of Pharmacology, 987, 13 . doi:10.1016/j.ejphar.2024.177161 -
NLM
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161 -
Vancouver
Silva JCL da, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WF da, Bendit I, Ridley AJ, Rego EM, Velloso EDRP, Costa-Lotufo LV, Machado Neto JA. Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells [Internet]. European Journal of Pharmacology. 2025 ; 987 13 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.ejphar.2024.177161 - Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia
- Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models
Informações sobre o DOI: 10.1016/j.ejphar.2024.177161 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
